𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acute glucocorticoid effects on the multicomponent model of working memory

✍ Scribed by Leonardo José Vaz; Márcia Pradella-Hallinan; Orlando Francisco Amodeo Bueno; Sabine Pompéia


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
141 KB
Volume
26
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis


Objective

In comparison with basal physiological levels, acute, high levels of cortisol affect learning and memory. Despite reports of cortisol‐induced episodic memory effects, no study has used a comprehensive battery of tests to evaluate glucocorticoid effects on the multicomponent model of working memory. Here, we report the results of a double‐blind, placebo‐controlled, between‐subjects study.

Methods

Twenty healthy young men were randomly assigned to either acute cortisol (30 mg hydrocortisone) or placebo administration. Participants were subjected to an extensive cognitive test battery that evaluated all systems of the multicomponent model of working memory, including various executive domains (shifting, updating, inhibition, planning and access to long‐term memory).

Results

Compared with placebo, hydrocortisone administration increased cortisol blood levels and impaired working memory in storage of multimodal information in the episodic buffer and maintenance/reverberation of information in the phonological loop. Hydrocortisone also decreased performance in planning and inhibition tasks, the latter having been explained by changes in storage of information in working memory.

Conclusions

Thus, hydrocortisone acutely impairs various components of working memory, including executive functioning. This effect must be considered when administering similar drugs, which are widely used for the treatment of many clinical disorders. Copyright © 2011 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Overexpression of mineralocorticoid and
✍ Deveroux Ferguson; Robert Sapolsky 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

## Abstract It is well established that mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs) influence hippocampal‐dependent spatial memory. MRs are saturated in the presence of low corticosterone (CORT) levels; consequently receptor protein levels play a rate‐limiting role in regul

Effects of Smoking and Smoking Deprivati
✍ JONATHAN BLAKE; ANDREW SMITH 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

This study examined the eects of smoking and smoking deprivation on the articulatory loop of working memory. Forty subjects (20 smokers and 20 non-smokers) performed tasks involving serial recall of letters on two occasions 1 week apart. In each test one part was conducted with articulatory suppress

Acute effects of the work environment on
✍ Dr. Kelley J. Donham; Donald C. Zavala; James Merchant 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

A sample population of ownerloperators of swine confinement production facilities (21 subjects in 21 different facilities) were tested by spirometry immediately before and after a 4-hr work period. These confinement workers had statistically significant decrements in flow rates ranging from 3.3% (me

The Effect of a Working Memory Load on t
✍ Suzanna L. Penningroth; Peter Graf; Jennifer M. Gray 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Summary The intention‐superiority effect refers to the finding that intentions are more accessible than other memory contents. Our primary goal was to test for automatic processing in this effect, testing three features of automaticity: unintentionality, effortlessness, and lack of awareness. We

Bridged nicotine, isonicotine, and noris
✍ Edward D. Levin; M. Imad Damaj; William Glassco; Everett L. May; Billy R. Martin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Nicotine and other nicotinic agonists have been found to improve performance in a variety of tasks, including the radial-arm maze to improve memory. There has been an active effort to develop novel nicotinic agonists for the treatment of cognitive dysfunction such as is seen in Alzheimer's disease.